NCT05662202Phase 3Completed

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Study sponsor: Biofrontera Inc. · BFRI

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2025-09-03Actual
Enrollment · participants172Actual
Source updated2026-08-21Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Overall subject complete response rate

+ After

Measure: Overall Subject Complete Response Rate

Check registry source

· 1 field changed

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source